Volume 3, Issue 9
Commentaryp. 803
Overcoming resistance in chronic myeloid leukemia
Author(s): Rupali Roy & Moshe Talpaz
Conference Reportp. 811
11th International Congress on Targeted Anticancer Therapies
Author(s): Valrerie Helin, Ohad Hammer, Jean-Pierre Armand
Editorialp. 817
Adult ADHD: an area lacking in clinical research?
Author(s): Josep Antoni, Ramos-Quiroga & Miren Ochoa Sagues
Clinical Trail Methodologyp. 823
When should the sequential parallel comparison design be used in clinical trials?
Author(s): Lee Baer, Anastasia Ivanova
Clinical Trail Methodologyp. 835
Challenges in clinical trial design for recurrent glioblastoma
Author(s): Katharine A McNeill, Howard A Fine
Clinical Trail Methodologyp. 849
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Author(s): Meenakshi Devidas, James R Anderson
Review: Clinical Trail Outcomesp. 859
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Author(s): Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomesp. 875
Treatment of Clostridium difficile infection: recent trial results
Author(s): Sarah S Lewis, Deverick J Anderson
Review: Clinical Trail Outcomesp. 887
Pneumococcal vaccination in adults: recent evidence from clinical trials and observational studies
Author(s): M Allen Moseley, Mark T Dransfield
Review: Clinical Trail Outcomesp. 899
Monoclonal antibody therapy for classical Hodgkin lymphoma
Author(s): Ewa Paszkiewicz-Kozik ,an Walewski
Acknowledgementsp. 911
